These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 25329640

  • 21. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.
    Gören Z, J Demirkapu M, Akpinar Acet G, Çali S, Gülçebi Idriz Oğlu M.
    Turk J Med Sci; 2017 Feb 27; 47(1):47-54. PubMed ID: 28263519
    [Abstract] [Full Text] [Related]

  • 22. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.
    Abbas A, Al-Shaibi S, Sankaralingam S, Awaisu A, Kattezhathu VS, Wongwiwatthananukit S, Owusu YB.
    Int J Clin Pharm; 2022 Apr 27; 44(2):348-356. PubMed ID: 34811600
    [Abstract] [Full Text] [Related]

  • 23. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF, Akinwumi AA, Ademola OA, Oluwole BA, Ibiene EO.
    Niger Postgrad Med J; 2017 Apr 27; 24(2):88-92. PubMed ID: 28762362
    [Abstract] [Full Text] [Related]

  • 24. Risk factors for potential drug-drug interactions in intensive care unit patients.
    Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, Babić GM.
    J Crit Care; 2018 Feb 27; 43():1-6. PubMed ID: 28822348
    [Abstract] [Full Text] [Related]

  • 25. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
    Gülçebi İdriz Oğlu M, Küçükibrahimoğlu E, Karaalp A, Sarikaya Ö, Demirkapu M, Onat F, Gören MZ.
    Turk J Med Sci; 2016 Apr 19; 46(3):812-9. PubMed ID: 27513261
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases.
    Liu Y, Wang J, Gong H, Li C, Wu J, Xia T, Li C, Li S, Chen M.
    Ann Transl Med; 2023 Jan 15; 11(1):17. PubMed ID: 36760261
    [Abstract] [Full Text] [Related]

  • 27. Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants.
    Yeh ML, Chang YJ, Yeh SJ, Huang LJ, Yen YT, Wang PY, Li YC, Hsu CY.
    Comput Methods Programs Biomed; 2014 Jan 15; 113(1):15-22. PubMed ID: 24209715
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
    Laban AA, Birand N, Chukwunyere U, Abdi A, Basgut B.
    Niger J Clin Pract; 2021 Jul 15; 24(7):1067-1071. PubMed ID: 34290184
    [Abstract] [Full Text] [Related]

  • 29. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R, AbdulHameed MDM, Kumar K, Yu X, Wallqvist A, Reifman J.
    BMC Pharmacol Toxicol; 2017 Jun 08; 18(1):44. PubMed ID: 28595649
    [Abstract] [Full Text] [Related]

  • 30. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
    Eyal S, Rasaby S, Ekstein D.
    Epilepsy Behav; 2014 Feb 08; 31():369-76. PubMed ID: 24211058
    [Abstract] [Full Text] [Related]

  • 31. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
    Fernández de Palencia Espinosa MA, Díaz Carrasco MS, Fuster Soler JL, Ruíz Merino G, De la Rubia Nieto MA, Espuny Miró A.
    Int J Clin Pharm; 2014 Dec 08; 36(6):1160-9. PubMed ID: 25204258
    [Abstract] [Full Text] [Related]

  • 32. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H, Moutaouakkil Y, Sefrioui MR, Moukafih B, Bousliman Y, Bennana A, Lamsaouri J, Makram S, Cherrah Y.
    Pan Afr Med J; 2018 Dec 08; 29():225. PubMed ID: 30100979
    [Abstract] [Full Text] [Related]

  • 33. [Drug-drug interactions in intensive care patients].
    Saaby L, Olesen C, Fedder J, Haunstrup E.
    Ugeskr Laeger; 2009 Sep 21; 171(39):2817-22. PubMed ID: 19811752
    [Abstract] [Full Text] [Related]

  • 34. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R, Baer R, Aparasu A.
    Res Social Adm Pharm; 2007 Dec 21; 3(4):426-37. PubMed ID: 18082877
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y, Tan SL, Chan A, Wong YP, Yong WP, Ng RC, Lim SW, Salim A.
    Clin Ther; 2012 Aug 21; 34(8):1696-704. PubMed ID: 22795926
    [Abstract] [Full Text] [Related]

  • 36. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
    Teixeira JJ, Crozatti MT, dos Santos CA, Romano-Lieber NS.
    PLoS One; 2012 Aug 21; 7(10):e47062. PubMed ID: 23071711
    [Abstract] [Full Text] [Related]

  • 37. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
    Hasan SS, Lim KN, Anwar M, Sathvik BS, Ahmadi K, Yuan AW, Kamarunnesa MA.
    Singapore Med J; 2012 Aug 21; 53(8):526-31. PubMed ID: 22941130
    [Abstract] [Full Text] [Related]

  • 38. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC, Glassman PA, Marks IR, Fowler C, Castiglione B, Good CB.
    J Manag Care Pharm; 2003 Aug 21; 9(6):513-22. PubMed ID: 14664659
    [Abstract] [Full Text] [Related]

  • 39. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL, Varma DM, Immadisetti K, Rajesh R, Vidyasagar S, Guddattu V.
    Int J Risk Saf Med; 2017 Aug 21; 29(1-2):25-55. PubMed ID: 28885219
    [Abstract] [Full Text] [Related]

  • 40. Assessing patients' information needs regarding drug-drug interactions.
    Mutebi A, Warholak TL, Hines LE, Plummer R, Malone DC.
    J Am Pharm Assoc (2003); 2013 Aug 21; 53(1):39-45. PubMed ID: 23636154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.